ACE2 and cancer: The SLC6A20 interactingprotein TMEM27, an ACE2 homologue, and its pan-cancer expression profilinganalysis suggests the involvement of SLC6A20 in providingincreased susceptibility of COVID-19 disease in cancer patients.